Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy
Open Access
- 22 June 2020
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 98 (10), 743-747
- https://doi.org/10.1159/000509434
Abstract
Background: To date, the clinical characteristics of coronavirus disease 19 (COVID-19)-infected urologic cancer patients are unknown. Methods: We have analyzed all patients with prostate cancer undergoing hormonal or chemotherapy treatment and receiving telephone and in person pre-triage between March 1 and 27, 2020, at the Tortora Hospital, Pagani, Italy. Results: Among 72 patients, 48 and 24 were hormone-sensitive (HS) and castration-resistant prostate cancer (CRPC), respectively; 0 HS and 2 (8.3%) CRPC (p < 0.05) were positive for COVID-19. Both patients were receiving LHRH agonist therapy, and 1 patient was receiving enzalutamide. Urgent intensive care unit admission was required due to clinical worsening. Blood tests showed severe lymphopenia, anemia, and an increase in platelets. Retroviral therapy, antibiotics, heparin, and chloroquine were prescribed at the beginning. One patient also received tocilizumab as a salvage treatment. After 3 weeks of hospitalization, the patients were discharged from the hospital. Both patients suffered from an aggressive COVID-19 course due to concomitant comorbidities. Conclusions: Investigating whether hormonal therapy, especially in advanced disease, acts as a protective factor or a risk factor during COVID-19 could be useful.Keywords
This publication has 14 references indexed in Scilit:
- Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort studyThe Lancet Oncology, 2020
- Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2-3European Urology, 2020
- COVID 19 therapies and anti-cancer drugs: A systematic review of recent literatureCritical Reviews in Oncology/Hematology, 2020
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)Annals of Oncology, 2020
- Coronavirus Disease (COVID-19) in Italy: Analysis of Risk Factors and Proposed Remedial MeasuresFrontiers in Medicine, 2020
- Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcomeEuropean Journal of Cancer, 2020
- Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposureAnnals of Oncology, 2020
- Apalutamide and overall survival in non-metastatic castration-resistant prostate cancerAnnals of Oncology, 2019
- Androgen-Induced ImmunosuppressionFrontiers in Immunology, 2018
- Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndromePediatric Research, 2017